Results 1 to 10 of about 5,388 (136)

Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress

open access: yesEMBO Molecular Medicine, 2020
Chemotherapy still constitutes the standard of care for the treatment of most neoplastic diseases. Certain chemotherapeutics from the oncological armamentarium are able to trigger pre‐mortem stress signals that lead to immunogenic cell death (ICD), thus ...
Wei Xie   +2 more
exaly   +2 more sources

GEFT inhibits the GSDM-mediated proptosis signalling pathway, promoting the progression and drug resistance of rhabdomyosarcoma [PDF]

open access: yesCell Death and Disease
The metastasis or recurrence of rhabdomyosarcoma (RMS) is the primary cause of tumour-related deaths. Patients with high-risk RMS have poor prognosis with a 5-year overall survival rate of 20–30%.
Fan Yang   +11 more
doaj   +2 more sources

A scientometric and comparative study of rhabdomyosarcoma research by pediatricians and stomatologists [PDF]

open access: yesJournal of Dental Sciences
Background/purpose: Rhabdomyosarcoma (RMS) frequently affects pediatric patients and common occurs in the head and neck region. The purpose of this study was to compare the scientometric characteristics of RMS publications by pediatricians and ...
Wenke Chen   +3 more
doaj   +2 more sources

Progressive Metastatic Cutaneous <italic>TFCP2::FUS</italic> Fusion-Positive Rhabdomyosarcoma: A Case Report [PDF]

open access: yesCase Reports in Oncology
Introduction: Rhabdomyosarcoma (RMS) rarely exhibits the TFCP2::FUS gene fusion and is even more rarely present as multiple cutaneous lesions.
Dustine Reich   +4 more
doaj   +2 more sources

Access to pediatric oncology medicine in Iran: a cross-sectional survey in Urmia [PDF]

open access: yesBMC Pediatrics
Background Cancer stands as a significant cause of mortality among children and adolescents, imposing a considerable burden on global healthcare. The World Health Organization (WHO) reports a stark imbalance in the accessibility of cancer medicines ...
Kiana Baghban   +4 more
doaj   +2 more sources

Drug Repurposing for Targeting ISL LIM Homeobox 2 in Treatment of Endometriosis: A Computational Study [PDF]

open access: yesInternational Journal of Fertility and Sterility
Background: Endometriosis is a prevalent women's health disorder that lacks a definitive cure. Numerous studies have been conducted to identify the underlying causes of this disease and select the most effective pharmaceutical intervention.
Soodeh Mahdian   +4 more
doaj   +2 more sources

Potential secondary metabolite from Indonesian Actinobacteria (InaCC A758) against Mycobacterium tuberculosis [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2021
Objective(s): This study explored Indonesian Actinobacteria which were isolated from Curcuma zedoaria endophytic microbes and mangrove ecosystem for new antimycobacterial compounds.
Maya Rakhmawatie   +5 more
doaj   +1 more source

Uterine artery chemoembolization for management of unrupturedinterstitial pregnancy diagnosed in the early first trimester

open access: yesClinical and Experimental Obstetrics & Gynecology, 2022
Background: With the increased frequency of diagnosis of interstitial pregnancy in the early first trimester, non-surgical management of unruptured interstitial pregnancy has become an important issue.
Akihiro Takeda   +3 more
doaj   +1 more source

Galanginin Protects AML-12 Cells Against Dactinomycin Induced Hepatotoxicity

open access: yesNamık Kemal Tıp Dergisi, 2023
Aim:The purpose of this study was to evaluate the effects of galanginin (Gal) on dactinomycin induced hepatotoxicity in vitro.Materials and Methods:AML-12 cell line was divided into 4 groups as the control, Gal, dactinomycin, and Gal+dactinomycin groups.
Melek AKINCI   +3 more
doaj   +1 more source

Pneumocystis jirovecii pneumonia complicating methotrexate treatment in a patient with low-risk post-molar gestational trophoblastic neoplasia: A case report and review of the literature

open access: yesGynecologic Oncology Reports, 2023
Low-risk gestational trophoblastic neoplasia (GTN) is generally treated with single agent chemotherapy, including methotrexate (MTX) or dactinomycin.
Hector S. Porragas-Paseiro   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy